Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Update on Mystery Illness

By HospiMedica staff writers
Posted on 03 Apr 2003
A team of scientists in the department of microbiology, University of Hong Kong, has successfully cultured the viral agent that causes severe acute respiratory syndrome (SARS) and has made progress in developing a reliable diagnostic test.

The basic test relies on the technique of neutralizing antibodies. More...
In experiments to determine the test's accuracy, scientists found it was able to detect tell-tale antibodies in sera taken from eight SARS patients. This early test will now be further developed into a more sophisticated diagnostic test. "This spectacular achievement is an example of what the world can do when the intellectual resources of nations around the world are focused on a single problem,” said Klaus Stohr, a virologist with the World Health Organization (WHO, Geneva, Switzerland), who is coordinating the global laboratory network.

Canadian researchers have released findings suggesting that the metapneumovirus, which belongs to the paramyxoviridae family, may be the cause of SARS. However, mounting evidence points to a member of the coronavirus family, according to WHO scientists. WHO has established a network of doctors and laboratories who have had experience with SARS. They are using e-mail and teleconferencing to exchange and compare information as quickly as possible.

A new wave of SARS cases has been reported in Vietnam and Singapore, according to WHO. However, following the initial reports of explosive outbursts of the illness among healthcare workers and the rapid spread of the illness, barrier precautions appear to have greatly reduced further spread among healthcare workers in many countries. Barrier precautions include the wearing of gowns, gloves, masks, and goggles. WHO guidelines state that after their discharge, SARS patients should be carefully monitored for a week. Also, WHO is asking airports in cities affected to query international passengers about their health and to discourage travel in those having experienced a fever in the prior 24 hours.




Related Links:
WHO

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.